A mechanistic approach to antiepileptic drug interactions.
about
The Impact of Anti-Epileptic Drugs on Growth and Bone MetabolismStiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channelsOptimal prevention of seizures induced by high-dose busulfanFor dioxin-induced birth defects, mouse or human CYP1A2 in maternal liver protects whereas mouse CYP1A1 and CYP1B1 are inconsequentialPhenobarbital influence on neuromuscular block produced by rocuronium in rats.Pharmacoepidemiologic investigation of a clonazepam-valproic acid interaction by mixed effect modeling using routine clinical pharmacokinetic data in Japanese patients.Detection of alcohol abuse in neurological patients: variables of clinical relevance to the accuracy of the %CDT-TIA and CDTect methods.Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results.Clinically significant pharmacokinetic drug interactions between antiepileptic drugs.Vigabatrin: a novel therapy for seizure disorders.Phenytoin as a possible cause of acetaminophen hepatotoxicity: case report and review of the literature.The 'apparent clearance' of free phenytoin in elderly vs. younger adultsAntiepileptic drug interactions.Strategies for optimizing antiepileptic drug therapy in elderly people.New anti-epileptic drugs for the 21st century.Phenobarbital for the treatment of epilepsy in the 21st century: a critical review.Pharmacokinetics of aripiprazole and concomitant lithium and valproate.Drug reaction with eosinophilia and systemic symptoms syndrome probably induced by a lamotrigine-ginseng drug interaction.Can valproic acid be an inducer of clozapine metabolism?Potential interaction between ritonavir and carbamazepine.Attenuated hypocholesterolemia following severe trauma signals risk for late ventilator-associated pneumonia, ventilator dependency, and death: a retrospective study of consecutive patientsRequired propofol dose for anesthesia and time to emerge are affected by the use of antiepileptics: prospective cohort study.Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomasClinically relevant drug interactions with antiepileptic drugsAltered cytochrome p450 metabolism of calcineurin inhibitors: case report and review of the literature.Induction of endogenous pathways by antiepileptics and clinical implications.Optimizing antiepileptic drug therapy in the elderly.Can paracetamol (acetaminophen) be administered to patients with liver impairment?Optimizing pediatric dosing: a developmental pharmacologic approach.Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults.Extracorporeal removal techniques for the poisoned patient: a review for the intensivist.Blood-brain barrier P450 enzymes and multidrug transporters in drug resistance: a synergistic role in neurological diseases.Psychotropic drug-drug interactions involving P-glycoprotein.Repurposing valproate, enteral clonidine, and phenobarbital for comfort in adult ICU patients: a literature review with practical considerations.The effect of pioglitazone on pharmacokinetics of carbamazepine in healthy rabbits.Three patients needing high doses of valproic Acid to get therapeutic concentrationsPhenytoin and fluorouracil interaction.Significant reduction of sertraline plasma levels by carbamazepine and phenytoin.Phenytoin-diazepam interaction.Effect of over-the-counter cimetidine on phenytoin concentrations in patients with seizures.
P2860
Q26739054-7F03C418-6E9D-449F-88A7-134396347435Q28237504-5700DD04-DABA-4ACB-A9D4-7FD7E7581BF4Q28301571-0E01BC87-3FE6-449F-A130-BC44D0C168BBQ28586157-2D18DF29-C5B8-4E30-9C15-0D1306F1625BQ29346966-EC6055F4-8258-43A7-8024-EF7536E42CDAQ30885206-6B1092F6-28A5-486F-93E7-63CAE8A2DAB6Q31993722-E655921C-E175-4AF1-9512-E253EEF96DBAQ33382342-11FB2998-C7DB-4532-A8CB-8551AD02B6F4Q33668831-502781AD-5052-41D5-AC74-F676378A4060Q33814543-5B8D2A0C-5BE0-46FF-BF16-592E3E532AC2Q33839774-A6D5824C-489D-4C4A-9A47-358156752A4DQ34019379-602184AE-72F8-48C2-8B69-A68252CDDD00Q34090583-5E446D1F-C2BE-42B1-A1B9-F08F5D618D84Q34118987-2DB1B4CD-2464-4A5E-B576-3DB739AA3326Q34182061-92E95E54-0207-436C-B448-11172066FE5AQ34343308-C203539C-9203-4B0D-A2AC-6611640BCA10Q34376865-C92CBBB0-9F1A-45DE-9C5C-3445D1D46BD9Q34466478-AC00C1E4-258A-4B4E-A593-F230C2AF003DQ34497477-29B31CDC-9694-47C8-979A-DDC656A8DCA2Q34509811-289C467E-9D43-43C0-857A-894728B78281Q34677388-191CF929-A979-44CB-99CB-328E707C9D85Q35191123-0F129522-945A-4ABE-880F-86C3C7E036DBQ35403440-5A81560B-7658-4C89-A17A-A766A9B6F156Q35827491-71B56A57-672E-4373-8D40-DF3CDB1CC0FEQ36188339-37FC54A2-5EA1-4C9D-8E00-E1019AC4F505Q36263605-EFDBAD29-CC77-4D78-ADA9-B08378F84F19Q36270316-15EA97C3-3BD3-435F-B3B8-9923DAADCD01Q36802077-8A81C608-FD2B-41F0-BAB1-665938FE6302Q37498862-5CA5886C-D29C-4356-80C5-8ABBA23B50A7Q37598636-58D848BB-E7B1-44CD-9A48-F579E2932020Q37742957-D7EE2F54-28F3-4113-B42B-796CCAE25CB9Q37875183-DD128C39-9422-4C0D-9F23-7770361A2EC1Q38047816-D45FC64A-1DE9-436A-8297-F13EE959FD80Q38612210-8664A1DE-977D-421F-A309-43D89C4DD221Q40316980-ECB91AE3-33F9-45ED-89A9-92493A08DDDFQ40523894-AD566C80-B3E4-42D2-A0A3-5B61709AE552Q43809478-172BF42A-6C76-4C69-9B6D-F0B0BA2D5AFEQ43949974-B2C602BD-A426-4A41-88EE-E07AEC8B80DFQ44412601-43BFF434-F6C1-4A26-8CEA-4FC09ACA9B0CQ44863587-33F14E70-7994-451D-A1AF-8B5A5AB433A4
P2860
A mechanistic approach to antiepileptic drug interactions.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
A mechanistic approach to antiepileptic drug interactions.
@ast
A mechanistic approach to antiepileptic drug interactions.
@en
A mechanistic approach to antiepileptic drug interactions.
@nl
type
label
A mechanistic approach to antiepileptic drug interactions.
@ast
A mechanistic approach to antiepileptic drug interactions.
@en
A mechanistic approach to antiepileptic drug interactions.
@nl
prefLabel
A mechanistic approach to antiepileptic drug interactions.
@ast
A mechanistic approach to antiepileptic drug interactions.
@en
A mechanistic approach to antiepileptic drug interactions.
@nl
P2860
P356
P1476
A mechanistic approach to antiepileptic drug interactions.
@en
P2093
G D Anderson
P2860
P304
P356
10.1345/APH.17332
P407
P577
1998-05-01T00:00:00Z